Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 75

Effects of Prucalopride on Gut Recovery After Colorectal Surgery

Official title: The Effect of Different Doses of Prucalopride on Improving Gut Function Recovery Following Elective Colorectal Surgery: a Randomized, Double-blind Study

Run by Future University in Egypt · NCT06816407 · Data updated 2026-11-12

This study is testing if a higher dose of prucalopride can help people recover their bowel function faster after colorectal surgery compared to a lower dose and a placebo.

More Post-Op Complication trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment180 (estimated)
SponsorFuture University in Egypt
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedMarch 2, 2025
Main results expectedMay 2025
Study endsMay 2025
Registry record updatedMarch 19, 2025
Trial IDNCT06816407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults undergoing elective colorectal surgeries such as colectomy or rectal resection.

Probably not a fit

Patients undergoing emergency surgeries, total colectomies, or those with pre-existing gastrointestinal disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of varying doses of prucalopride, a selective serotonin 5-HT4 receptor agonist, on gut function recovery in patients undergoing elective colorectal surgery. It aims to determine whether a higher dose of 4 mg can accelerate bowel function return and reduce hospital stay compared to a standard dose of 2 mg and a placebo. The study addresses the common postoperative complication of ileus, which can delay recovery and prolong hospitalization. By examining the efficacy of different dosing regimens, the research seeks to optimize pharmacological management for postoperative ileus.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery times and reduced hospital stays for patients after colorectal surgery.

How similar studies have gone: Previous studies have shown promise with prucalopride in enhancing gastrointestinal recovery, but this specific dosing approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* undergoing elective colorectal surgery, including but not limited to colectomy, rectal resection, and sigmoid resection.

Exclusion Criteria:

* Emergency surgery
* Total colectomy
* Creation of a stoma
* Pre-existing gastrointestinal disorders
* Severe renal or hepatic impairment
* Known hypersensitivity to prucalopride.

Where it's running

  • Matareya Hospital
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.